Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01828255
Other study ID # TF-1212
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date March 2013
Est. completion date May 2014

Study information

Verified date September 2020
Source Sensimed AG
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate how the intraocular pressure (IOP) varies in time and if the IOP variations are associated with the worsening of glaucoma. IOP patterns will be recorded continuously over 24 hours with SENSIMED Triggerfish® (TF) a portable investigational device using a contact lens sensor. After completing the Triggerfish lens placement and removal; the patient will complete a formal Polysomnography.


Recruitment information / eligibility

Status Terminated
Enrollment 40
Est. completion date May 2014
Est. primary completion date May 2014
Accepts healthy volunteers No
Gender All
Age group 40 Years to 89 Years
Eligibility Inclusion Criteria:

- Age between 40 and 89 years old

- Diagnosis of treated POAG (including normal tension glaucoma (NTG))

- All IOP measurements during the VF period (to be described further) equal or lower than 18 mmHg and/or on average equal or lower than 16 mmHg in the same period

- Documented glaucomatous VF damage at baseline, characterized by glaucoma hemifield test result outside normal limits on at least 2 consecutive VF tests or the presence of at least 3 contiguous test points within the same hemifield on the pattern deviation plot at p<0.01, with at least 1 point at p < 0.005

- At least 8 visual field tests carried out within at least 2 years, all with fixation losses and false positive/negative results equal or less than 33%

- For fast progressing eyes, 1) pointwise progression defined as two or more adjacent VF test locations in the same hemifield that show a threshold sensitivity rate of change more negative than -1.0 dB/year with p<0.01 or 2) a global rate of VF change based on mean deviation (MD) more negative than -1.0 dB/year

- For slowly or minimally progressing eyes a VF MD rate of change more positive than -0.5 dB/year with no significant pointwise progression as described above

- Not more than 6 diopters spherical equivalent on the study eye

- Have given written informed consent, prior to any investigational procedures

Exclusion Criteria:

- Baseline VF MD more negative than -15 dB. The rationale here is that in severely damaged visual fields, one may not be able to detect and measure rates of progression due to a 'floor effect'

- Corneal or conjunctival abnormality precluding contact lens adaptation

- Severe dry eye syndrome or other ocular disease

- Patients with angle closure glaucoma, traumatic glaucoma or uveitic glaucoma

- Patients with previous intraocular surgery in the enrolled eye, including cataract surgery

- Patients with allergy to corneal anesthetic

- Patients with contraindications for silicone contact lens wear

- Patients not able to understand the character and individual consequences of the investigation

- Participation in unrelated clinical research within the last 4 weeks

Study Design


Related Conditions & MeSH terms


Intervention

Device:
SENSIMED Triggerfish®


Locations

Country Name City State
United States The New York Eye and Ear Infirmary New York New York

Sponsors (1)

Lead Sponsor Collaborator
Sensimed AG

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Relationship Between 24-hour IOP Pattern as Recorded by TF and VF Progression in Patients With POAG. 24-hour measurement of TF, corresponding to IOP-related fluctuations expressed in arbitrary units of mini volts equivalent (mVeq) and comparison of this measurement between POAG patients showing fast and slow rates of glaucoma visual field progression. 24-hour
Secondary Relationship Between TF Pattern and VF Progression According to TF Slope Measurement of TF, corresponding to IOP-related fluctuations expressed in arbitrary units of mini volts equivalent (mVeq) and comparison of this measurement between POAG patients showing fast and slow rates of glaucoma visual field progression during wake vs sleep periods. The wake slope corresponds to the change in the TF signal from 1 hour before to 1 hour after the time the subject went to sleep. The sleep slope corresponds to the change from 1 hour before to 1 hour after the time the subject awoke. 24-hour
Secondary Relationship Between TF Pattern and VF Progression According to Day and Night TF measurement during diurnal and nocturnal periods and comparison of this measurement between POAG patients showing fast and slow rates of glaucoma visual field progression. 24-hour
Secondary Relationship Between 24-hour TF Pattern and VF Progression According to TF Peak Number of peaks in 24-Hours TF pattern, defined as the local maximum point in the smoothed TF profile. 24-hour
Secondary 24-hour TF IOP Pattern in Patients With POAG With Fast and Slow Rates of VF Progression Comparison (Spearman correlations) between 24-hour IOP-related fluctuations measured by TF and 24-hour blood pressure profiles (systolic, diastolic and mean arterial blood pressure) of POAG patients showing fast and slow rates of glaucoma visual field progression. The correlation between TF and blood pressure measurement was calculated within each subject then mean values were obtained for patients with slow vs fast glaucoma visual field progression. 24-hour